More on ENTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.22 |
|
|||
| Open | $1.20 | ||||
| 52 Wk High | $0.30 | ||||
| 52 Wk Low | $0.10 | ||||
| Day High | $1.24 | ||||
| Day Low | $1.20 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 53,289 | ||||
- Form DEFA14A Entera Bio Ltd.
- Form ARS Entera Bio Ltd. For: Jun 03
- Form DEF 14A Entera Bio Ltd. For: Jun 03
- Entera Bio's EB613 data selected for presentation at ENDO 2026
- Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipelin
- Form EFFECT Entera Bio Ltd.
- Form 424B3 Entera Bio Ltd.
- Form PRE 14A Entera Bio Ltd. For: May 14
- Entera Bio Ltd. (ENTX) Tops Q1 EPS by 4c
- Form 4 Entera Bio Ltd. For: May 07 Filed by: Galitzer Hillel
Entities mentioned with ENTX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Layoffs | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
